TGFB1 and benign prostatic hyperplasia: Furthermore, KQR reduced the expression of TGF-β1 and inhibited the phosphorylation of Smad2 and Smad3, blocking the TGF-β/Smad signaling pathway and thereby inhibiting the development of BPH.